10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 341 filers reported holding 10X GENOMICS INC in Q2 2021. The put-call ratio across all filers is 0.17 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,558,325 | +59.9% | 62,020 | +116.5% | 0.01% | +16.7% |
| Q2 2023 | $1,599,648 | +635.2% | 28,647 | +634.5% | 0.01% | +100.0% |
| Q1 2023 | $217,581 | -17.1% | 3,900 | -45.8% | 0.00% | -40.0% |
| Q4 2022 | $262,368 | -61.9% | 7,200 | +104.8% | 0.01% | -78.3% |
| Q2 2021 | $689,000 | -19.3% | 3,516 | -25.5% | 0.02% | -53.1% |
| Q1 2021 | $854,000 | -45.7% | 4,718 | -57.5% | 0.05% | -53.3% |
| Q4 2020 | $1,574,000 | +42.1% | 11,114 | +25.1% | 0.10% | -14.6% |
| Q3 2020 | $1,108,000 | +413.0% | 8,884 | +266.7% | 0.12% | +156.2% |
| Q2 2020 | $216,000 | – | 2,423 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |